A 38-year-old woman with severe community-acquired pneumonia is intubated and admitted to the ICU. On day 3, she develops progressive hypoxemia (PaO₂/FiO₂ = 95 on FiO₂ 1.0 and PEEP 12 cm H₂O), bilateral infiltrates on CT chest, and PAWP 14 mmHg. She is on lung-protective ventilation with Pplat 28 cm H₂O. Despite maximal conventional management, oxygenation remains critically low. Which of the following is the most appropriate next step?

Explanation

## Diagnosis: Severe ARDS with Refractory Hypoxemia **Key Point:** PaO₂/FiO₂ = 95 on maximal conventional support (FiO₂ 1.0, PEEP 12) defines severe ARDS with refractory hypoxemia. Patient is already on lung-protective ventilation with acceptable plateau pressure. ## Rescue Therapies for Refractory Hypoxemia in ARDS ### Prone Positioning **High-Yield:** The PROSEVA trial (2013) demonstrated that early prone positioning (initiated within 48 hours of ARDS onset) in severe ARDS reduces 28-day and 90-day mortality by ~16% and ~13%, respectively. **Clinical Pearl:** Prone positioning works by: 1. Redistributing perfusion away from dependent (dorsal) lung regions 2. Improving ventilation–perfusion matching 3. Recruiting dorsal atelectatic lung units 4. Reducing ventilator-induced lung injury **Mnemonic: PRONE Benefits = VAPE** - **V** = Ventilation–perfusion matching improves - **A** = Atelectasis reduction (dorsal recruitment) - **P** = Perfusion redistribution - **E** = Early application (within 48 hrs) is key ### Extracorporeal Membrane Oxygenation (ECMO) **Key Point:** ECMO is indicated for severe ARDS refractory to conventional and rescue therapies (including prone positioning). The EOLIA trial (2018) showed ECMO does not improve 60-day mortality as a standalone therapy but may benefit specific subgroups (e.g., younger patients, early referral, shorter pre-ECMO duration). **Clinical Pearl:** ECMO is considered when: - PaO₂/FiO₂ remains <50 despite maximal conventional + prone positioning - OR predicted mortality >50% with conventional therapy - Reversible underlying cause expected - No absolute contraindications (e.g., terminal illness, uncorrectable coagulopathy) ### Treatment Algorithm ```mermaid flowchart TD A[Severe ARDS: PaO₂/FiO₂ < 100]:::outcome --> B[Lung-protective ventilation + PEEP optimization]:::action B --> C{Response adequate?}:::decision C -->|Yes| D[Continue current strategy]:::action C -->|No| E[Initiate prone positioning]:::action E --> F[Reassess after 24-48 hours]:::action F --> G{PaO₂/FiO₂ improved?}:::decision G -->|Yes| H[Continue prone positioning]:::action G -->|No| I[Consider ECMO referral]:::urgent I --> J[Assess candidacy: age, comorbidities, reversibility]:::decision J -->|Suitable| K[Initiate veno-venous ECMO]:::action J -->|Not suitable| L[Supportive care / comfort measures]:::outcome ``` **Warning:** Do NOT increase tidal volume or switch to high-frequency oscillatory ventilation in refractory ARDS — both increase mortality and cause further lung injury.